CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,780 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 2,779 shares (to pay taxes)
- 4 Shares withheld for taxes President gave up 2,779 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 1,068 shares (to pay taxes)
- 4 Shares withheld for taxes President gave up 2,771 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 6,400 shares (to pay taxes)
- 4 Shares withheld for taxes President gave up 281 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 780 shares (to pay taxes)
- 4 Planned sale Chief Legal Officer sold 529 shares at $44.68 ($23,637)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Legal Officer sold 112 shares at $43.30 ($4,849)
- 4 Planned sale President sold 314 shares at $43.30 ($13,595)
- 4 Planned sale Chief Financial Officer sold 1,420 shares at $42.79 ($60,761)
- 4 Planned sale Chief Legal Officer sold 1,418 shares at $42.79 ($60,675)
- 4 Planned sale President sold 291 shares at $42.79 ($12,452)
- 4 Planned sale President sold 277 shares at $46.10 ($12,771)
- 4 Planned sale Chief Financial Officer sold 715 shares at $60.12 ($42,986)
- 4 Derivatives Options or other derivatives
Page 6 of 54 · 1,067 filings